DAILY EQUITY REPORT BY EPIC RESEARCH-31 SEPTEMBER 2012
-
Upload
epic-research-private-limited -
Category
Business
-
view
93 -
download
0
description
Transcript of DAILY EQUITY REPORT BY EPIC RESEARCH-31 SEPTEMBER 2012
HEADLINES
Indian Market
Indian equity markets down by -1.06% .
Nifty down by 56.55 pts and settle at 5258.50
Sensex down by 160.89 pts at 17380.75
Bank Nifty down by 94.70 pts at 9990.50
Global Market
European markets were up with FTSE up by 35.41 pts at 5754.86 ,CAC up by 45.30 pts at 3424.41 and DAX up by 88.44 pts at 6983.93
Dow future down by 74.00 pts at
13056.00
WWW.EPICRESEARCH.CO 09993959693
DAILY EQUITY NEWSLETTER 3RD SEPTEMBER 2012
HEADLINES
• Q1 GDP grows at 5.5%, languishes
around 3-year low.
• Q1 FY13 GDP at 5.5%: RBI unlikely to
cut interest rates.
• US companies assure support to
India's Infra Debt Fund.
• Big blow for Sahara as Supreme Court
orders group to refund 17400 crore to
investors.
FII’s and DII’s
CATEGORY DATE BUY SELL NET
FII 31-Aug-12 3084.38 3295.46 -211.08
DII 31-Aug-12 1114.32 1286.86 -172.54
NIFTY DAILY PIVOTS
PIVOT R4 R3 R2 R1 PP S1 S2 S3 S4
NIFTY 5461 5396 5331 5294 5266 5229 5201 5136 5071
WWW.EPICRESEARCH.CO 09993959693
MARKET ANALYSIS:
Key benchmark indices edged lower in choppy trade after the latest data showed that the nation's GDP
growth languished around its lowest in three years in Q1 June 2012.
The BSE Sensex was down 160.89 points or 0.92% to 17,380.75. The index tumbled 204.03 points at
the day's low of 17,337.61 in mid-afternoon trade, its lowest level since 6 August 2012. The index
rose 15.98 points at the day's high of 17,557.62 in opening trade.
The S&P CNX Nifty was down 59.40 points or 1.12% to 5,255.65, as per provisional figures. The
index hit a low of 5,238.90 in intraday trade, its lowest level since 3 August 2012. The index hit high
of 5,303.25 in intraday trade.
The market breadth, indicating the overall health of the market, was negative. On BSE, 1,450 shares
fell and 1,351 shares rose. A total of 129 shares were unchanged.
Index heavyweight Reliance Industries (RIL) lost 2.07% to Rs 765.80. Index heavyweight and cigarette
maker ITC declined 0.76% to Rs 267.75. GlaxoSmithKline Consumer Healthcare rose 1.86% to Rs
2966. Procter & Gamble Hygiene and Health Care gained 3.5% to Rs 2460.
STOCKS TO WATCH
AMBUJA
HDFC BANK
RANBAXY
POLARIS
SCRIPS IN BAN PERIOD
COREEDUTEC
MCDOWELL-N
-
www.epicresearch.co 09993959693
.
EXPERT OPINION
NIFTY
Nifty looks sideways
Strategy: Buy on dips, sell on rise
Support:5280
Resistance:5350
BANK NIFTY
Bank Nifty looks sideways
Strategy: Buy on dips, sell on rise
Support:10020
Resistance:10150
GAINERS AND LOOSERS
PREVIOUS PERFORMANCE
TYPE SCRIP B/S RESULT
CASH SBI B TGT ACHIEVED
CASH POWER GRID B NOT EXECUTED
FUTURE POLARIS B NOT EXECUTED
FUTURE RANBAXY B TGT ACHIEVED
DAILY NIFTY GAINERS
SCRIPS RATE VOL.
(000)
PR.
CLOSE
NET
CHANGE
%
CHANGE
Bharti Airtel
247.8 6093.23 242.85 4.95 2.04
HDFC 735.3 20084.2
9 726.6 8.7 1.2
Cipla 376.45 3405.17 372.3 4.15 1.11
Grasim
2989.8 36.11 2975.9 13.9 0.47
Ranbaxy
551.7 888.18 549.5 2.2 0.4
DAILY NIFTY LOOSERS
SCRIPS RATE VOL.
(000)
PR.
CLOSE
NET %
CHANGE
BPCL 334.85 734.14 348 -13.1 -3.78
Hero MotoCorp
1763 576.33 1823.6 -60.6 -3.32
IDFC 134.05 10868.28 138.45 -4.4 -3.18
Kotak Mahindra
Bank 574.1 687.18 592.55 -18.4 -3.11
BHEL 213.25 4566.35 219.1 -5.85 -2.67
.
MARKET CALLS
CASH
SCRIPS ACTION LEVEL 1ST
TARGET 2ND
TARGET 3RD
TARGET STOP LOSS
AMBUJA SELL 183.55 181.00 178.50 175.50 185.50
HDFC BANK SELL 589.50 585.50 580.00 573.00 596.10
FUTURE
SCRIPS ACTION LEVEL 1ST
TARGET 2ND
TARGET 3RD
TARGET STOP LOSS
ONGC SELL 273.40 120.70 122.20 124.70 127.70
RANBAXY BUY 555.00 558.00 562.00 566.00 551.00
Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable.
This material is for personal information and based upon it & takes no responsibility
The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein, togethe r with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer.
All Rights Reserved. Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.